Pneumonectomy after chemoradiation
Open Access
- 18 January 2008
- Vol. 112 (5) , 1106-1113
- https://doi.org/10.1002/cncr.23283
Abstract
BACKGROUND.: The current study was conducted to examine the outcomes of pneumonectomy after induction chemoradiotherapy in patients with locally advanced nonsmall cell lung cancer (NSCLC).METHODS.: All patients undergoing pneumonectomy after induction therapy at the Brigham and Women's Hospital were retrospectively evaluated for 30‐day and 100‐day mortality and treatment‐related complications with Institutional Review Board approval. Multivariate and univariate analyses for clinical factors correlating with toxicity and/or survival were calculated.RESULTS.: Between 1995 and 2005, 73 patients underwent pneumonectomy for NSCLC after induction therapy. All patients received radiation (median dose of 54 gray [Gy]) and 69 patients (95%) received concurrent chemotherapy. The median age was 62 years and 43 patients (59%) were male; Thirty‐seven patients (51%) had American Joint Committee on Cancer stage IIIA NSCLC, 27 (37%) had stage IIIB, 6 had stage IIB, and 4 had stage IV NSCLC because of a resected solitary brain metastasis. A majority (44; 60%) of patients received the combination of carboplatin and paclitaxel, whereas 15 (21%) received the combination of cisplatin and etoposide. Forty‐five patients (62%) underwent left pneumonectomy. With a median follow‐up of 28 months, the 1‐year and 2‐year overall survival rates were 70% and 49%, respectively. The 30‐day and 100‐day mortality rates were 6% and 10%, respectively. Only 4 of 73 patients (6%) died of acute respiratory distress syndrome. The rate of nonfatal treatment‐related morbidity was 11%. On univariate analysis, right‐sided pneumonectomy was associated with a higher risk of treatment‐related mortality (P= .099).CONCLUSIONS.: With an acceptable mortality rate, a single‐institutional series demonstrated that trimodality therapy including pneumonectomy can be safely accomplished in patients with advanced NSCLC. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 26 references indexed in Scilit:
- Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer.Trends over time and 20-year institutional experienceEuropean Journal of Cardio-Thoracic Surgery, 2006
- Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 StudyJournal of Clinical Oncology, 2005
- Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancerLung Cancer, 2005
- Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyLung Cancer, 2004
- Induction chemoradiation and surgical resection for non–small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)The Journal of Thoracic and Cardiovascular Surgery, 2001
- Long-term survival of surgical cases of lung cancerLung Cancer, 1995
- Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.Journal of Clinical Oncology, 1995
- Survival and prognosis following resection of primary non small cell bronchogenic carcinomaEuropean Journal of Cardio-Thoracic Surgery, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Results of radical treatment of stage IIIa non-small-cell carcinoma of the lungEuropean Journal of Cardio-Thoracic Surgery, 1988